Publication:
SARS-CoV-2 and influenza viruses: strategies to cope with coinfection and bioinformatics perspective

Thumbnail Image

Organizational Units

Program

KU-Authors

KU Authors

Co-Authors

Ghaznavi, H
Shirvaliloo, M.
Sargazi, S.
Mohammadghasemipour, Z.
Shams, Z.
Hesari, Z.
Shahraki, O.
Sheervalilou, R.
Shirvalilou S.

Advisor

Publication Date

2022

Language

English

Type

Review

Journal Title

Journal ISSN

Volume Title

Abstract

Almost a century after the devastating pandemic of the Spanish flu, humankind is facing the relatively comparable global outbreak of COVID-19. COVID-19 is an infectious disease caused by SARS-CoV-2 with an unprecedented transmission pattern. In the face of the recent repercussions of COVID-19, many have argued that the clinical experience with influenza through the last century may have tremendous implications in the containment of this newly emerged viral disease. During the last 2 years, from the emergence of COVID-19, tremendous advances have been made in diagnosing and treating coinfections. Several approved vaccines are available now for the primary prevention of COVID-19 and specific treatments exist to alleviate symptoms. The present review article aims to discuss the pathophysiology, diagnosis, and treatment of SARS-CoV-2 and influenza A virus coinfection while delivering a bioinformatics-based insight into this subject matter.

Description

Source:

Cell Biology International

Publisher:

Wiley

Keywords:

Subject

Cell biology

Citation

Endorsement

Review

Supplemented By

Referenced By

Copy Rights Note

0

Views

3

Downloads

View PlumX Details